January 16, 2024 12:56 PM | 3 min read
“Start 2024 Strong With 3 Hot Stock Ideas – Practically Free”
Ready for your shot at the next potential 32%, 39% or 45% gains in today’s market? You’re about to miss Stock Expert Gianni Di Poce’s 3 latest stock ideas… Ones that could shift your entire wealth-building journey. If you’re ready to start 2024 strong with 12 hot stock ideas every single month. ACT FAST.
On Tuesday cannabis stocks and ETFs started the trading day on a positive note following the release of documents related to the Department of Health and Human Service‘s (HHS) review of cannabis late last week.
Investors seem optimistic about potential regulatory changes that could benefit the cannabis industry after the Dept. of Health and Human Services (HHS) finally released 252 pages of documents on Friday confirming for the first time that the HHS recommended that the DEA reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you’ll also get Benzinga’s ultimate morning update AND a free $30 gift card and more!
The documents explain that cannabis “has a currently accepted medical use in treatment in the United States” and that it has a “potential for abuse less than the drugs or other substances in Schedules I and II.”
Assistant Secretary for Health Rachel Levine, one of the top officials at HHS wrote a letter dated Aug. 29 to Drug Enforcement Agency administrator Anne Milgram in August calling for marijuana to be reclassified as a Schedule III drug under the Controlled Substances Act.
In an interview with The New York Times, Xavier Becerra, the Secretary of HHS, stated that his department had conveyed their stance and shared their comprehensive scientific review with the DEA in response to President Joe Biden’s scheduling directive.
“We continue to offer them any follow-up, technical information if they have any questions,” Becerra said.
See also: DEA’s Cannabis Classification: Time To Right A Decades-Old Mistake As Feds Confirm Marijuana’s Medical Benefits
Before You Do Another Thing, Invest In Your Future With Options
Want to become an options master? In his special 90% discount, Nic Chahine will give you full access to his top options plays, including strategies he’s used to bag two-digit winners. Learn Nic’s time-tested strategies ASAP. Buy here for only $0.99.
While Biden’s administration is making progress in cannabis reforms, albeit slowly, one of the top marijuana legalization proponents in Congress is losing his patience.
“I’ve been working for 50 years leading the effort to end the failed, unfair, cynical, dangerous war on drugs that targeted Black people, that discouraged the illegal use of a therapeutic good—something that could have enriched our economy but instead criminalized behavior,” Rep. Earl Blumenauer (D-OR) said in a speech on the House floor last week.
Yet, he highlighted there’s still time for the present Congress to bring about rational changes in marijuana legislation, as reported by Marijuana Moment’s Kyle Jaeger.
Now read: Reschedule Cannabis Or ‘Abolish The DEA,’ Says Physician: Examining The 50-Year-Old, Trillion-Dollar Agency
Here’s how some of the top US and Canadian cannabis stocks are trading at the moment of writing on Tuesday morning:
- Curaleaf Holdings Inc‘s (OTCQX:CURLF) shares are trading 5.1087% higher at $4.835 per share.
- Green Thumb Industries Inc‘s (OTCQX:GTBIF) shares are trading 5.34% higher at $13.22 per share.
- Cresco Labs Inc‘s (OTC:CRLBF) shares are trading 14.82% higher at $2.216 per share.
- Verano Holdings Corp‘s(OTC:VRNOF) shares are trading 1.75% higher at $5.23 per share.
- Trulieve Cannabis Corp‘s (OTCQX:TCNNF) (CSE:TRUL) shares are trading 9.85% higher at $6.69 per share.
- The Cannabist Company Holdings Inc‘s (NEO: CBST) (OTCQX:CBSTF) (FSE: 3LP) shares are trading 5.82% higher at $0.56 per share.
- WM Technology, Inc.‘s (NASDAQ:MAPS) shares are trading 5.13% higher at $0.9451 per share.
- Canopy Growth Corp‘s (TSX:WEED) (NASDAQ:CGC) shares are trading 9.07% higher at $4.93 per share.
- Tilray Brands Inc‘s (NYSE:TLRY) shares are trading 6.68% higher at 1.995 per share.
Here’s how some of the best-performing cannabis ETFs are trading at the moment of writing on Tuesday morning:
- AdvisorShares Pure US Cannabis ETF‘s (NASDAQ:MSOS) shares are trading 7.44% higher at $8.81 per share.
- ETFMG Alternative Harvest ETF‘s (NYSE:MJ) shares are trading 5.7185% higher at $3.605 per share.
- AdvisorShares MSOS 2x Daily ETF‘s (NYSE:MSOX) shares are trading 14.59% higher at $5.51 per share.
- AdvisorShares Pure Cannabis ETF‘s (NYSE:YOLO) shares are trading 7.30% higher at $3.5732 per share.
- Amplify Seymour Cannabis ETF‘s (NYSE:CNBS) shares are trading 6.5% higher at $4.9098 per share.
- ETFMG U.S. Alternative Harvest ETF‘s (NYSE:MJUS) shares are trading 7.65% higher at $2.0083 per share.
“Start 2024 Strong With 3 Hot Stock Ideas – Practically Free”
Ready for your shot at the next potential 32%, 39% or 45% gains in today’s market? You’re about to miss Stock Expert Gianni Di Poce’s 3 latest stock ideas… Ones that could shift your entire wealth-building journey. If you’re ready to start 2024 strong with 12 hot stock ideas every single month. ACT FAST.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.